FFL
AMED

Financial Freedom LLC’s Amedisys AMED Stock Holding History

Financial Freedom LLC’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-100
Closed -$9.84K – 358
2025
Q2 		$9.84K Hold
100
– – 0.01% 273
2025
Q1 		$9.26K Hold
100
– – 0.01% 284
2024
Q4 		$9.08K Hold
100
– – ﹤0.01% 280
2024
Q3 		$9.65K Hold
100
– – 0.01% 276
2024
Q2 		$9.18K Hold
100
– – 0.01% 282
2024
Q1 		$9.22K Hold
100
– – 0.01% 277
2023
Q4 		$9.51K Hold
100
– – 0.01% 270
2023
Q3 		$9.34K Hold
100
– – 0.01% 277
2023
Q2 		$9.14K Hold
100
– – 0.01% 285
2023
Q1 		$7.36K Hold
100
– – 0.01% 294
2022
Q4 		$8.35K Buy
+100
New +$9.02K 0.01% 285

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Financial Freedom LLC's AMED Position: Q3 2025 in Review

Financial Freedom LLC sold out of Amedisys (AMED) in Q3 2025, closing a stake of 100 shares — an estimated $9.84K sold.

Financial Freedom LLC first reported a position in AMED in Q4 2022 and held it in 11 quarters. The position peaked at $9.84K in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Financial Freedom LLC reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Financial Freedom LLC sold 100 Amedisys shares in Q3 2025, an estimated $9.84K.
  • Financial Freedom LLC first reported a position in Amedisys in Q4 2022 and held it in 11 quarters.
  • Financial Freedom LLC's Amedisys position peaked at $9.84K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Financial Freedom LLC's 13F filing for Q3 2025, filed 13 Nov 2025.